Michelle Marks, DO
- Call 216.448.6400
Additional Locations
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Michelle Marks, DO
Michelle Marks, DO, FAAP, SFHM is a Staff physician in the Department of Pediatric Hospital Medicine at Cleveland Clinic Children's Hospital and Vice-Chair of the Pediatric Institute, Medical Director, Cleveland Clinic Children's Hospital for Rehabilitation.
Dr. Marks earned a doctor of osteopathic medicine at Ohio University College of Osteopathic Medicine and completed a pediatric internship at Doctor’s Hospital in Columbus, Ohio before coming to Cleveland Clinic for her residency where she served as chief pediatric resident. Board-certified by the American Board of Pediatrics in General Pediatrics and Pediatric Hospital Medicine. Dr. Marks is licensed to practice medicine in Ohio.
Listed in the 2006- 2019 edition of “Best Doctors in America,” Dr. Marks won a “Distinguished Teaching” award from the Division of Pediatrics and the Taylor Koose Compassionate Care award. She is a member of the American Academy of Pediatrics and the Society for Hospital Medicine.
Education & Professional Highlights
Appointed
1993
Education & Fellowships
Residency - Cleveland Clinic
Pediatrics
Cleveland,
OH
1996
Internship - Doctors Hospital
Columbus,
OH
1993
Medical Education - Ohio University College of Osteopathic Medicine
Athens,
OH
1992
Undergraduate - University of Toledo
Biology
Toledo,
OH United States
1988
Certifications
- Pediatrics
- Pediatrics - Pediatric Hospital Medicine
Awards & Honors
- Best Doctors in America, 2006, 2007
Research & Publications
See publications for Michelle Marks, DO.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/8/2024, Dr. Marks has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.